Delivery Order SPE2DR25D1053-SPE2DR26FV997
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Anastrozole 1 mg tablets in a quantity of 90 units, with a contract ceiling value of $1,898.16. The award, issued on September 16, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 17, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Anastrozole 1 mg tablets (90-count) on August 7, 2025, with a ceiling value of $1,351.55 and completion date of August 8, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The award reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,290.24 by the Defense Logistics Agency on January 12, 2026, for the supply of Anastrozole 1 mg tablets in quantities of 30 units. The contract carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will be completed at the awardee's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 13, 2026....
- The Defense Logistics Agency awarded a delivery order valued at $73,658.77 to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in quantities of 30 units. This firm fixed-price, competitively awarded delivery order was issued on January 13, 2026, with an ultimate completion date of January 14, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating open...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,157.20 contract is for the delivery of 4,560,051,951 units of Anastrozole 1 mg tablets. The contract has an ultimate completion date of February 27, 2023 and was awarded on February 24, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $225.73 to Amerisourcebergen Drug Corporation for the supply of 4561357537 units of 1 mg Anastrozole tablets. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle and calls for Amerisourcebergen to deliver the specified pharmaceutical to a facility in Conshohocken, Pennsylvania, with performance required between June 27-28, 2023. As a leading provider of pharmaceuticals and...
- The Defense Logistics Agency awarded a delivery order valued at $18,694.72 to AmerisourceBergen Drug Corp for the supply of ARIMIDEX (anastrozole) 1 mg tablets in quantities of 30 on January 22, 2026, with an ultimate completion date of January 23, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,862.78 to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in a quantity of 30 units. This competitive, firm fixed-price delivery order was issued on January 29, 2026, with an ultimate completion date of January 30, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under a larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $44,901.48 to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in quantities of 30, with an ultimate completion date of November 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,305.87 to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in a 30-count package. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by December 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV997Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,128.00 to AmerisourceBergen Drug Corp for the supply of Anastrozole 1 mg tablets in quantities of 90 units. This competitive award, issued on February 3, 2026, with an ultimate completion date of February 4, 2026, represents a firm fixed-price transaction with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office and primary operations. This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s comprehensive Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This prime contract vehicle serves as the primary mechanism for supplying a broad range of pharmaceutical products, medical supplies, specialty medications, vaccines, and related commodities to support military healthcare programs globally. The Anastrozole delivery represents a typical task order fulfillment under this expansive pharmaceutical supply agreement that enables efficient procurement of essential medications for military treatment facilities and federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 2/2/26 |